loadpatents
name:-0.11596298217773
name:-0.021987915039062
name:-0.014995098114014
Xu; Qingguo Patent Filings

Xu; Qingguo

Patent Applications and Registrations

Patent applications and USPTO patent grants for Xu; Qingguo.The latest application filed is for "nanoparticles with enhanced mucosal penetration or decreased inflammation".

Company Profile
6.6.14
  • Xu; Qingguo - Glen Allen VA
  • Xu; Qingguo - Baltimore MD
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
PPAR.alpha. agonist compositions and methods of use
Grant 11,369,575 - Ma , et al. June 28, 2
2022-06-28
Nanoparticles With Enhanced Mucosal Penetration Or Decreased Inflammation
App 20210196829 - Hanes; Justin ;   et al.
2021-07-01
PPARa AGONIST COMPOSITIONS AND METHODS OF USE
App 20200297651 - Ma; Jian-xing ;   et al.
2020-09-24
Glutaminase Inhibitor Discovery And Nanoparticle-enhanced Delivery For Cancer Therapy
App 20200246274 - Kind Code
2020-08-06
Glutaminase inhibitor discovery and nanoparticle-enhanced delivery for cancer therapy
Grant 10,660,861 - Hanes , et al.
2020-05-26
Method for production of aerated water-in-oil emulsions and aerated emulsions
Grant 10,588,327 - Aldred , et al.
2020-03-17
Methods of making drug loaded microfiber sutures for ophthalmic application
Grant 10,471,172 - Kashiwabuchi , et al. Nov
2019-11-12
Sunitinib Formulations And Methods For Use Thereof In Treatment Of Ocular Disorders
App 20190275001 - Fu; Jie ;   et al.
2019-09-12
Glucocorticoid-loaded nanoparticles for prevention of corneal allograft rejection and neovascularization
Grant 10,195,212 - Hanes , et al. Fe
2019-02-05
Sunitinib Formulations And Methods For Use Thereof In Treatment Of Ocular Disorders
App 20170273901 - Fu; Jie ;   et al.
2017-09-28
Glutaminase Inhibitor Discovery And Nanoparticle-enhanced Delivery For Cancer Therapy
App 20170209387 - Hanes; Justin ;   et al.
2017-07-27
Glucocorticoid-loaded Nanoparticles For Prevention Of Corneal Allograft Rejection And Neovascularization
App 20170157147 - Hanes; Justin Scot ;   et al.
2017-06-08
Drug Loaded Microfiber Sutures For Ophthalmic Application
App 20170087271 - Kashiwabuchi; Fabiana Kimie ;   et al.
2017-03-30
Drug loaded microfiber sutures for ophthalmic application
Grant 9,533,068 - Kashiwabuchi , et al. January 3, 2
2017-01-03
Method For Production Of Aerated Water-in-oil Emulsions And Aerated Emulsions
App 20160338372 - ALDRED; DEBORAH LYNNE ;   et al.
2016-11-24
Edible Fat Continuous Product Comprising Sucrose Fatty Acid Ester And Particulate Anti-spattering Agent
App 20160219895 - BOT; Arjen ;   et al.
2016-08-04
Method For Production Of Aerated Water-in-oil Emulsions And Aerated Emulsions
App 20150327565 - ALDRED; Deborah Lynne ;   et al.
2015-11-19
Aerated Oil Containing Sucrose Fatty Acid Ester And Hydrophobin
App 20150086701 - Bot; Arjen ;   et al.
2015-03-26
Nanoparticles With Enhanced Mucosal Penetration Or Decreased Inflammation
App 20140329913 - Hanes; Justin ;   et al.
2014-11-06
Drug Loaded Microfiber Sutures for Ophthalmic Application
App 20130296933 - Kashiwabuchi; Fabiana Kimie ;   et al.
2013-11-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed